Axa’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Axa’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-18,921	Closed	-$562K	–	1257
2021 Q4	$562K	Sell	18,921 -18,826	-50%	-$769K	﹤0.01%	1014
2021 Q3	$1.93M	Buy	37,747 +697	+2%	+$49.6K	0.01%	861
2021 Q2	$4.53M	Sell	37,050 -2	-0%	-$311	0.01%	732
2021 Q1	$6.84M	Buy	37,052 +287	+0.8%	+$68K	0.02%	623
2020 Q4	$10.1M	Buy	36,765 +155	+0.4%	+$39K	0.03%	521
2020 Q3	$8.57M	Buy	+36,610	New	+$9.18M	0.03%	504

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Axa's FRLN Position: Q1 2022 in Review

Axa sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q1 2022, closing a stake of 18,921 shares — an estimated $562K sold.

Axa first reported a position in FRLN in Q3 2020 and held it in 6 quarters. The position peaked at $10.1M in Q4 2020. 19 funds tracked by Wall St. Rank hold FRLN as of Q1 2022.

Axa reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Axa sold 18,921 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q1 2022, an estimated $562K.
Axa first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 6 quarters.
Axa's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $10.1M in Q4 2020.
19 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q1 2022.

Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.